NCT03548805View on ClinicalTrials.gov

Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 16, 2018

Primary Completion Date

April 1, 2023

Study Completion Date

May 19, 2023

Conditions
Open Angle Glaucoma
Interventions
PROCEDURE

ologen® Collagen Matrix

Ologen is a collagen matrix used to modulate wound healing in the postoperative period to promote diffuse blebs

PROCEDURE

Trabeculectomy with low dose mitomycin C

Trabeculectomy with low dose MMC

Trial Locations (1)

500034

L V Prasad Eye Institute, Hyderabad

All Listed Sponsors
lead

L.V. Prasad Eye Institute

OTHER

NCT03548805 - Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma | Biotech Hunter | Biotech Hunter